Navigation Links
NxStage Drives to Educate Kidney Patients

LAWRENCE, Mass., July 16, 2014 /PRNewswire/ -- NxStage® Medical, Inc. (NASDAQ: NXTM), a leading manufacturer of innovative dialysis products, announced today the launch  of the NxStage Freedom Tour, a two week road trip in a recreational vehicle  to promote and educate dialysis patients on the benefits of home hemodialysis with the NxStage System One™.  Traveling in the NxStage Freedom Coach are NxStage field marketing specialists Charissa Rice and Harvey Wells. During the nine city tour, the duo will make stops outside of dialysis centers in Maryland, Pennsylvania, Connecticut, Massachusetts, New Jersey, New York, Virginia and North Carolina. Patients and care partners are invited inside the NxStage Freedom coach to watch Rice, who is also a NxStage user,  perform her treatments with her care partner, learn about home hemodialysis and hear first-hand how the therapy has helped both Rice and Wells to reclaim their lives.

"NxStage has given me the freedom to live my life the way I want to live it," said Rice. "I want to help patients like me understand that they can have the life they want, and show them how great I feel, how happy I am, and how independently I live."

Rice performed home hemodialysis with the NxStage System One from 2009 until she received a transplant in 2011. She returned to NxStage therapy after her transplant failed in 2013, knowing home hemodialysis would help her lead the life she wanted. Wells, began in-center treatment following the failure of his first kidney transplant in 2006, then began dialyzing with the System One from the comfort of his home in 2007 until he received a second transplant in 2011. During the last three years of Wells' therapy, he teamed up with NxStage and travelled more than 60,000 miles to 150 dialysis centers helping to increase awareness among patients, care partners and dialysis professionals about the potentially life-changing benefits of home hemodialysis.

"With kidney failure, many patients feel they can no longer enjoy travel because they are tethered to the dialysis center, and arranging for treatment while away can be daunting and inconvenient," said Joe Turk, NxStage's president. "We want to show people that with NxStage, travelling away from the center is once again a possibility, along with the simpler things in life like quality time with family and an active lifestyle."

To learn more about the NxStage Freedom Tour and where to meet Harvey and Charissa visit To learn more about NxStage and the System One, visit . Join the conversation on Facebook at, Twitter at @NxStage and YouTube at

Despite the health benefits that home hemodialysis may provide to those with chronic kidney disease, this form of therapy is not for everyone. The reported benefits of home hemodialysis may not be experienced by all patients. The risks associated with hemodialysis treatments in any environment include, but are not limited to, high blood pressure, fluid overload, low blood pressure, heart-related issues, and vascular access complications. The medical devices used in hemodialysis therapies may add additional risks including air entering the bloodstream and blood loss due to clotting or accidental disconnection of the blood tubing set. Certain risks are unique to the home. Treatments at home are done without the presence of medical personnel and on-site technical support. Patients and their partners must be trained on what to do and how to get medical or technical help if needed.

About the NxStage System One
The NxStage System One is the first and only truly portable hemodialysis system cleared for home use by the U.S. Food & Drug Administration (FDA). Its simplicity and revolutionary size (just over a foot tall) are intended to allow convenient use in patients' homes and give patients the freedom to travel with their therapy. When combined with the NxStage Pureflow SL Dialysis Preparation System, patients are able to further simplify, using ordinary tap water to create dialysis fluid. Unlike conventional hemodialysis systems, the System One requires no special infrastructure to operate. Under the guidance of their physician, patients can use the NxStage System One, with their trained partners, where, how and when it best meets their needs - at home or on vacation and at a medically appropriate treatment frequency.

About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a medical device company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of ESRD and acute kidney failure. For more information on NxStage and its products, please visit the Company's website at

Forward-Looking Statements
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Quarterly Report on Form 10-Q for the quarter ended March 31, 2014. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.

Media contact:
Meredith D'Agostino

Logo -

SOURCE NxStage Medical, Inc.
Copyright©2014 PR Newswire.
All rights reserved

Related medicine technology :

1. NxStage Increases Revenue Guidance for Fourth Quarter and Full-Year 2013
2. NxStage to Present at the 32nd Annual J.P. Morgan Healthcare Conference
3. NxStage Reports Third Quarter 2013 Financial Results
4. NxStage Medical Introduces New Products at 2013 American Society of Nephrology Meeting
5. NxStage Announces Fourth Quarter 2013 Investor Conference Schedule
6. NxStage Introduces Web-Based Dosing Calculator
7. NxStage Urges CMS to Fix Training Reimbursement to Provide Medicare Patients Greater Access to Life-Changing Home Hemodialysis Therapies
8. NxStage Reports Record Revenue For The Second Quarter Of Fiscal 2013
9. NxStage Congratulates Home Dialyzors United for Securing Policies through the US Department of Transportation to Improve the Air Travel Experience for Home Dialyzors
10. Jay Shreiner Joins NxStage Board of Directors
11. NxStage Announces New Agreements with DaVita
Post Your Comments:
(Date:6/23/2016)... , June 23, 2016 Roche (SIX: ... 510(k) clearance for its Elecsys BRAHMS PCT (procalcitonin) assay ... sepsis or septic shock. With this clearance, Roche is ... a fully integrated solution for sepsis risk assessment and ... with bacterial infection and PCT levels in blood can ...
(Date:6/23/2016)... Research and Markets has announced the addition of the ... offering. The current unmet ... for MedImmune to enter. The US ageing population creates a ... considerable growth for effective anti-influenza medications. The introduction of a ... development is still in its infancy. Key ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 If ... Leaders Scholarship is any indication, the future is in ... at by the Diabetes Scholars Foundation ... the way of academic and community service excellence. ... since 2012, and continues to advocate for people with ...
Breaking Medicine Technology:
(Date:6/26/2016)... Michigan (PRWEB) , ... June 26, 2016 , ... ... to fertility once they have been diagnosed with endometriosis. These women need a ... they also require a comprehensive approach that can help for preservation of fertility ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... "With 30 ... their specific project," said Christina Austin - CEO of Pixel Film Studios. , ... and all within Final Cut Pro X . Simply select a ProHand generator ...
(Date:6/25/2016)... ... ... Friday, June 10, Van Mitchell, Secretary of the Maryland Department of Health and Mental ... exemplary accomplishments in worksite health promotion. , The Wellness at Work Awards took place ... BWI Marriott in Linthicum Heights. iHire was one of 42 businesses to receive an ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance ... and the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, ... Disease. , Sickle Cell Disease (SCD) is a disorder of the red blood cells, ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... for accelerated orthodontic treatment. Dr. Cheng has extensive experience with all areas of ... AcceleDent, and accelerated osteogenic orthodontics. , Micro-osteoperforation is a revolutionary adjunct to ...
Breaking Medicine News(10 mins):